Related Experiment Videos
Five years experience with the Quinton Permcath for vascular access
1Department of Nephrology, East Birmingham Hospital, UK.
Summary
The Quinton Permcath offers durable and safe vascular access for dialysis patients, particularly those with complex conditions. Survival rates indicate its utility in challenging situations despite some infection risks.
Area of Science:
- Nephrology
- Vascular Surgery
- Medical Devices
Background:
- Dialysis patients often require long-term vascular access.
- Traditional access methods may be unsuitable for certain patient groups.
- The Quinton Permcath is a type of central venous catheter for dialysis.
Purpose of the Study:
- To evaluate the efficacy and safety of the Quinton Permcath for long-term hemodialysis access.
- To assess catheter survival rates and complication profiles in a cohort of dialysis patients.
Main Methods:
- A retrospective analysis of 64 Quinton Permcath insertions in 51 dialysis patients over five years.
- Data collected included patient demographics, indications for use, catheter dwell time, survival rates, and complications.
- Complications analyzed included insertion-related issues, exit site infections, sepsis, thrombosis, and flow problems.
Main Results:
- Actuarial catheter survival rates at 1, 2, 3, and 4 years were 74%, 43%, 25%, and 12%, respectively.
- Common indications included exhausted peripheral access and contraindications to other methods.
- Minor insertion complications occurred; exit site infection and sepsis rates were 4.95 and 3.36 per 1000 catheter days.
- Catheter failure due to infection occurred in 18 cases; flow difficulties in six.
- Catheter sepsis contributed to two patient deaths; one subclavian/innominate vein thrombosis was noted.
Conclusions:
- The Quinton Permcath provides immediate, durable, and relatively safe vascular access for dialysis.
- It is a valuable option for patients facing difficult or contraindicated conventional access methods.
- Careful monitoring is necessary to manage infection and thrombosis risks associated with long-term use.